HIV Trials Should Focus On Pre-Treated Patients, FDA Guidance Says
Executive Summary
FDA is encouraging sponsors of HIV therapies to conduct more clinical trials in treatment-experienced patients
You may also be interested in...
FDA May Revisit Accelerated Approval For Oncology Products
FDA's oncology division is interested in revisiting the accelerated approval regulations as they apply to cancer treatments
Gilead Viread Virology Data Will Distinguish HIV Drug In Physician Promotions
Gilead will highlight Viread virology data to distinguish the HIV treatment in physician promotions
HIV Trial Modified Factorial Design Best For Study In Treated Patients - Cmte.
Modified factorial trial designs are the best strategy for studying new therapies in heavily treated HIV patients, FDA's Antiviral Drugs Advisory Committee suggested.